08 August 2021: Clinical Research
Magnetic Resonance Imaging (MRI)-Targeted Biopsy in Patients with Prostate-Specific Antigen (PSA) Levels <20 ng/mL: A Single-Center Study in Northeastern China
Zhihong Dai ABCDEF* , Yangyang Liu ABCDE* , Zhao Huangfu DF , Liang Wang CDEG* , Zhiyu Liu CDEG*DOI: 10.12659/MSM.930234
Med Sci Monit 2021; 27:e930234
Table 3 A comparative analysis of the CB and FB groups.
| CB | FB | P value | |
|---|---|---|---|
| Patients (n) | 118 | 100 | |
| MRI suspicious lesions | 149 | 116 | |
| Mean no. core per patients (SD) | 14.34 (±0.76) | 14.65 (±0.91) | 0.812 |
| Positive for any cancer, n (%) | 62 (52.54%) | 53 (53.00%) | 0.842 |
| Positive for clinically significant cancer, n (%) | 43 (36.44%) | 32 (32.00%) | 0.217 |
| Time required for surgery (min) | 23.42 (16–28) | 35.16 (30–45) | 0.016 |
| CB – cognitive fusion biopsy; FB – MRI software fusion-targeted biopsy; MRI – magnetic resonance imaging. | |||